The real-world experience of biologics for neuromyelitis optica spectrum disorders as first-line and switched therapy
Biologics were highly efficacious in preventing relapses of NMOSD with AQP4-IgG in real-world clinical practice.
Authors
- Kazunori Iwao
- Noriko Isobe (ORCID: https://orcid.org/0000-0001-9525-4254)
- Hajime Takeuchi (ORCID: https://orcid.org/0000-0002-2368-5087)
- Mitsuru Watanabe (ORCID: https://orcid.org/0000-0003-0831-623X)
- Yuu‐ichi Kira
- Ayano Matsuyoshi
- Koji Shinoda (ORCID: https://orcid.org/0000-0003-3818-9008)
- Keisuke Mizutani
- Katsuhisa Masaki
Institutions
- Kyushu University (JP)
Publication Details
- Journal
- Journal of Neuroimmunology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1016/j.jneuroim.2025.578799
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47